MXPA03009718A - Antibioticos glicopeptidicos ac-98-1; ac-98-2; ac-98-3; ac-98-4 y ac-98-5 substancialmente puros. - Google Patents
Antibioticos glicopeptidicos ac-98-1; ac-98-2; ac-98-3; ac-98-4 y ac-98-5 substancialmente puros.Info
- Publication number
- MXPA03009718A MXPA03009718A MXPA03009718A MXPA03009718A MXPA03009718A MX PA03009718 A MXPA03009718 A MX PA03009718A MX PA03009718 A MXPA03009718 A MX PA03009718A MX PA03009718 A MXPA03009718 A MX PA03009718A MX PA03009718 A MXPA03009718 A MX PA03009718A
- Authority
- MX
- Mexico
- Prior art keywords
- substantially pure
- glycopeptide antibiotics
- pure glycopeptide
- antibiotics
- microorganism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28624901P | 2001-04-25 | 2001-04-25 | |
PCT/US2002/013073 WO2002085403A1 (en) | 2001-04-25 | 2002-04-25 | Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03009718A true MXPA03009718A (es) | 2004-01-29 |
Family
ID=23097738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03009718A MXPA03009718A (es) | 2001-04-25 | 2002-04-25 | Antibioticos glicopeptidicos ac-98-1; ac-98-2; ac-98-3; ac-98-4 y ac-98-5 substancialmente puros. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1399176B1 (es) |
AT (1) | ATE489962T1 (es) |
CA (1) | CA2444907C (es) |
DE (1) | DE60238481D1 (es) |
ES (1) | ES2354686T3 (es) |
MX (1) | MXPA03009718A (es) |
WO (1) | WO2002085403A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002086141A1 (en) * | 2001-04-25 | 2002-10-31 | Wyeth Holdings Corporation | Glycopeptide antibiotics |
US6713448B2 (en) | 2001-04-25 | 2004-03-30 | Wyeth Holdings Corporation | Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3495004A (en) * | 1968-08-13 | 1970-02-10 | American Cyanamid Co | Antibiotic ac-98 and production thereof |
DE69031721T2 (de) * | 1989-07-18 | 1998-03-19 | Biosearch Italia Spa | Aus Dalbaheptide hergestellte Pentapeptid-Antibiotika |
KR100430202B1 (ko) * | 1995-07-05 | 2004-09-18 | 아벤티스 벌크 에스.피.에이. | 등전성 집속에 의한 달바 헵티드 항생제의 정제 |
KR20010071913A (ko) * | 1998-07-16 | 2001-07-31 | 말라테스티닉 니콜라스 피. | 노카티아신 항생 물질 |
-
2002
- 2002-04-25 DE DE60238481T patent/DE60238481D1/de not_active Expired - Lifetime
- 2002-04-25 CA CA2444907A patent/CA2444907C/en not_active Expired - Lifetime
- 2002-04-25 MX MXPA03009718A patent/MXPA03009718A/es active IP Right Grant
- 2002-04-25 EP EP02739179A patent/EP1399176B1/en not_active Expired - Lifetime
- 2002-04-25 ES ES02739179T patent/ES2354686T3/es not_active Expired - Lifetime
- 2002-04-25 WO PCT/US2002/013073 patent/WO2002085403A1/en not_active Application Discontinuation
- 2002-04-25 AT AT02739179T patent/ATE489962T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60238481D1 (de) | 2011-01-13 |
ES2354686T3 (es) | 2011-03-17 |
WO2002085403A1 (en) | 2002-10-31 |
ATE489962T1 (de) | 2010-12-15 |
EP1399176A4 (en) | 2009-02-11 |
CA2444907C (en) | 2015-02-24 |
EP1399176B1 (en) | 2010-12-01 |
EP1399176A1 (en) | 2004-03-24 |
CA2444907A1 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2414459A (en) | Car top carrier | |
AU2002365351A1 (en) | Rate selection for an ofdm system | |
AU2002327720A1 (en) | Single-carrier and multicarrier receiver architecture | |
AU2002307015A1 (en) | Distributed, scalable cryptographic access control | |
AU2002342091A1 (en) | Silicone priming compositions, articles and methods_____________ | |
AU2002244133A1 (en) | Delivery systems for mycotechnologies, mycofiltration and mycoremediation | |
WO2003023178A3 (en) | Adjustable expansion cone assembly | |
AU2003298498A1 (en) | Refrigerator | |
AU2002349042A1 (en) | 3,4-alkylenedioxy-thiophene copolymers | |
AU2002323415A1 (en) | Purge system | |
GB2377295A (en) | Conversational dealing system | |
AU2002346470A1 (en) | Rate selection for an ofdm system | |
EP1621549A3 (en) | Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments | |
MXPA04000541A (es) | Formulacion liofilizada de 2-metil-tieno-benzodiazepina. | |
EP2371833A3 (en) | 10-substituted macrolide antibiotics | |
EP1399176A4 (en) | ESSENTIALLY PURE GLYCOPEPTIDE ANTIBIOTICS AC-98-1; AC 98-2; AC 98-3; AC-98-4 AND AC-98-5 | |
AU2002366301A1 (en) | Messaging system | |
WO2002085310A3 (en) | Antibiotics aa-896 | |
AU5369399A (en) | Basic refractory ceramic hollow body | |
MX342808B (es) | Antibioticos de glicopeptidos. | |
EP1390056A4 (en) | Glycopeptide antibiotics | |
AUPR414701A0 (en) | Alpha 1,3 galactosyltransferase | |
AU4125699A (en) | Retinal calcium channel (alpha)1f-subunit gene | |
AU4605599A (en) | Weapon, especially an anti-armor weapon | |
AU2002213505A1 (en) | Process for the preparation of pgd2 antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status |